Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pasquale Persico

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Cancers|March 10, 2022
Precision Oncology in Lower-Grade Gliomas: Promises and Pitfalls of Therapeutic Strategies Targeting IDH-MutationsPasquale Persico, Elena Lorenzi, Agnese Losurdo, et al.
Cancers|February 10, 2024
T Cell Features in Glioblastoma May Guide Therapeutic Strategies to Overcome Microenvironment ImmunosuppressionAgnese Losurdo, Antonio Di Muzio, Beatrice Claudia Cianciotti, et al.
European Radiology|November 17, 2020
Prognostic relevance of temporal muscle thickness as a marker of sarcopenia in patients with glioblastoma at diagnosisRiccardo Muglia, Matteo Simonelli, Federico Pessina, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 7, 2022
Quality of life of adult cancer survivors enrolled in Humanitas Research Hospital's survivorship care modelElena Lorenzi, Lucia Morello, Laura Giordano, et al.
Immunobiology|November 10, 2019
Role of myeloid cells in the immunosuppressive microenvironment in gliomasChiara V Locarno, Matteo Simonelli, Claudia Carenza, et al.
Frontiers in Immunology|February 1, 2024
Refining patient selection for next-generation immunotherapeutic early-phase clinical trials with a novel and externally validated prognostic nomogramAgnese Losurdo, Angelo Dipasquale, Laura Giordano, et al.
Journal of Clinical Medicine|June 2, 2021
Role of 11C Methionine Positron Emission Tomography (11CMETPET) for Surgery and Radiation Therapy Planning in Newly Diagnosed Glioblastoma Patients Enrolled into a Phase II Clinical StudyFederico Pessina, Pierina Navarria, Elena Clerici, et al.
Cancer Treatment Reviews|November 12, 2024
PARP inhibitors in gliomas: Mechanisms of action, current trends and future perspectivesEugenia Cella, Alberto Bosio, Pasquale Persico, et al.
Neuro-Oncology Advances|December 13, 2021
Immunotherapeutic early-phase clinical trials and malignant gliomas: A single-center experience and comprehensive immunophenotyping of circulating leukocytesMatteo Simonelli, Pasquale Persico, Arianna Capucetti, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 25, 2026
Mapping integrated care for brain tumour-related epilepsy in the Italian RIN-IRCCS networkElena Anghileri, Alessia Marcassoli, Veronica Villani, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Cancers|March 10, 2022
Precision Oncology in Lower-Grade Gliomas: Promises and Pitfalls of Therapeutic Strategies Targeting IDH-MutationsPasquale Persico, Elena Lorenzi, Agnese Losurdo, et al.
Cancers|February 10, 2024
T Cell Features in Glioblastoma May Guide Therapeutic Strategies to Overcome Microenvironment ImmunosuppressionAgnese Losurdo, Antonio Di Muzio, Beatrice Claudia Cianciotti, et al.
European Radiology|November 17, 2020
Prognostic relevance of temporal muscle thickness as a marker of sarcopenia in patients with glioblastoma at diagnosisRiccardo Muglia, Matteo Simonelli, Federico Pessina, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 7, 2022
Quality of life of adult cancer survivors enrolled in Humanitas Research Hospital's survivorship care modelElena Lorenzi, Lucia Morello, Laura Giordano, et al.
Immunobiology|November 10, 2019
Role of myeloid cells in the immunosuppressive microenvironment in gliomasChiara V Locarno, Matteo Simonelli, Claudia Carenza, et al.
Frontiers in Immunology|February 1, 2024
Refining patient selection for next-generation immunotherapeutic early-phase clinical trials with a novel and externally validated prognostic nomogramAgnese Losurdo, Angelo Dipasquale, Laura Giordano, et al.
Journal of Clinical Medicine|June 2, 2021
Role of 11C Methionine Positron Emission Tomography (11CMETPET) for Surgery and Radiation Therapy Planning in Newly Diagnosed Glioblastoma Patients Enrolled into a Phase II Clinical StudyFederico Pessina, Pierina Navarria, Elena Clerici, et al.
Cancer Treatment Reviews|November 12, 2024
PARP inhibitors in gliomas: Mechanisms of action, current trends and future perspectivesEugenia Cella, Alberto Bosio, Pasquale Persico, et al.
Neuro-Oncology Advances|December 13, 2021
Immunotherapeutic early-phase clinical trials and malignant gliomas: A single-center experience and comprehensive immunophenotyping of circulating leukocytesMatteo Simonelli, Pasquale Persico, Arianna Capucetti, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|June 25, 2026
Mapping integrated care for brain tumour-related epilepsy in the Italian RIN-IRCCS networkElena Anghileri, Alessia Marcassoli, Veronica Villani, et al.
Pageof 3